Autoimmune and inflammatory disease stratification
4 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- CLINIQUES UNIVERSITAIRES SAINT-LUC ASBL
Brussels university hospital contributing clinical trial expertise in pain medicine, cancer immunotherapy, and patient stratification to European research consortia.
“3TR project on molecular mechanisms of treatment non-response in autoimmune and inflammatory diseases, contributing clinical samples and predictive modeling data.”
BE13 projects - FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO
Milan's leading IRCCS teaching hospital contributing clinical trials, patient cohorts, and translational expertise in regenerative medicine, autoimmunity, and neurodegeneration.
“3TR focuses on molecular mechanisms of treatment non-response across autoimmune conditions; IP-cure-B targets immune profiling for hepatitis B cure strategies.”
PrimaryIT10 projects - AZIENDA OSPEDALE UNIVERSITA PADOVA
Italian university hospital specializing in liver disease research, autoimmune disease stratification, and clinical validation within European consortia.
“3TR project applies predictive modeling, integrative genomics, and single-cell data to understand treatment non-response across autoimmune conditions.”
IT7 projects - FUNDACION PARA LA INVESTIGACION BIOSANITARIA DE ANDALUCIA ORIENTAL-ALEJANDRO OTERO
Andalusian biomedical research foundation providing clinical cohorts, biobank access, and hospital-network data to European health consortia.
“Contributed to 3TR, a major project on molecular mechanisms of treatment non-response using single-cell data and integrative genomics.”
ES4 projects